Daiichi Sankyo Co Ltd (DSNKY)
35.48
+1.92
(+5.71%)
USD |
OTCM |
May 02, 16:00
Daiichi Sankyo Cash from Investing (Quarterly): -473.86M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -473.86M |
| December 31, 2023 | -3.319B |
| September 30, 2023 | 811.42M |
| June 30, 2023 | 1.023B |
| March 31, 2023 | 44.95M |
| December 31, 2022 | -469.79M |
| September 30, 2022 | -1.687B |
| June 30, 2022 | 203.06M |
| March 31, 2022 | 373.81M |
| December 31, 2021 | -195.52M |
| September 30, 2021 | 1.439B |
| June 30, 2021 | 274.15M |
| March 31, 2021 | -1.374B |
| December 31, 2020 | 1.132B |
| September 30, 2020 | 530.62M |
| June 30, 2020 | -658.38M |
| March 31, 2020 | 444.44M |
| December 31, 2019 | 108.24M |
| September 30, 2019 | 147.98M |
| June 30, 2019 | 50.80M |
| March 31, 2019 | -616.32M |
| December 31, 2018 | 134.20M |
| September 30, 2018 | -519.41M |
| June 30, 2018 | -284.02M |
| March 31, 2018 | 409.18M |
| Date | Value |
|---|---|
| December 31, 2017 | -136.35M |
| September 30, 2017 | 346.30M |
| June 30, 2017 | 360.74M |
| March 31, 2017 | -25.23M |
| December 31, 2016 | -734.84M |
| September 30, 2016 | -601.32M |
| June 30, 2016 | 466.35M |
| March 31, 2016 | -698.65M |
| December 31, 2015 | 170.26M |
| September 30, 2015 | -126.53M |
| June 30, 2015 | 605.19M |
| March 31, 2015 | -700.69M |
| December 31, 2014 | 257.87M |
| September 30, 2014 | -248.92M |
| June 30, 2014 | 497.15M |
| March 31, 2014 | -611.55M |
| December 31, 2013 | -108.51M |
| September 30, 2013 | -638.36M |
| June 30, 2013 | -252.72M |
| March 31, 2011 | 319.53M |
| December 31, 2010 | -757.81M |
| September 30, 2010 | -92.84M |
| June 30, 2010 | -200.15M |
| March 31, 2010 | -239.91M |
| December 31, 2009 | 111.56M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.319B
Minimum
Dec 2023
1.439B
Maximum
Sep 2021
-79.75M
Average
128.11M
Median
Cash from Investing (Quarterly) Benchmarks
| AstraZeneca PLC | -2.413B |
| Eisai Co Ltd | -24.39M |
| Takeda Pharmaceutical Co Ltd | -460.58M |
| Nxera Pharma Co Ltd | -18.93M |
| PeptiDream Inc | -3.046M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 297.19M |
| Cash from Financing (Quarterly) | -45.43M |
| Free Cash Flow | 3.302B |
| Free Cash Flow Per Share (Quarterly) | -0.0224 |
| Free Cash Flow to Equity (Quarterly) | 94.99M |
| Free Cash Flow to Firm (Quarterly) | -42.98M |
| Free Cash Flow Yield | 4.85% |